InstantWhyThe deal
CNBC reports that Procter & Gamble will acquire supplements brand Thorne, according to CEO Shailesh Jejurikar. The CEO said the acquisition is a play to grow the company's health business. Neither company has released a statement confirming the deal, and financial terms have not been disclosed.
Why it matters
P&G's health business today centers on oral care, personal hygiene and over-the-counter medicines, making Thorne a new category entry rather than a bolt-on to existing brands. The move follows a pattern among consumer goods companies of expanding into higher-margin wellness products as growth in traditional household goods slows.
Deal context
Procter & Gamble has historically grown through acquisition of established brands in categories adjacent to its core business, from Gillette in shaving to Tampax in feminine care. The supplements industry has attracted interest from large consumer companies seeking exposure to health and wellness trends, though few major household goods players have made significant moves into the space. Johnson & Johnson recently took options on biotech companies including Sail Biomedicines in July 2026, though those deals targeted pharmaceutical technology rather than consumer supplements.
What has to happen next
The companies have not announced a timeline for closing the transaction or disclosed whether regulatory approval will be required. Procter & Gamble will need to clarify how Thorne fits into its existing health portfolio and whether the brand will be integrated or run independently.
- ✓Detected and written at 2026-08-04 15:41
- ✓First reported by CNBC
- ✓Written from public facts in our own words — never a copy
- ✓Published as fast as possible; our team holds editorial responsibility
Sources
- CNBC — Top News: https://www.cnbc.com/2026/08/04/procter-gamble-will-acquire-supplements-brand-thorne.html
More stories
InstantWhyTwo charged in federal drug trafficking probe in southern Maryland
InstantWhyNew Jersey sues Amazon over delivery contractor practices in antitrust case
InstantWhy